|
Originally published In Press as doi:10.1074/jbc.M707275200 on January 16, 2008
J. Biol. Chem., Vol. 283, Issue 15, 9713-9723, April 11, 2008
STAT3 and Oct-3/4 Control Histone Modification through Induction of Eed in Embryonic Stem Cells*
Hiroki Ura,
Masayuki Usuda1,
Keita Kinoshita,
Chuanhai Sun,
Keitaro Mori,
Tadayuki Akagi2,
Takahiko Matsuda3,
Hiroshi Koide4, and
Takashi Yokota
From the
Department of Stem Cell Biology, Graduate School of Medical Science, Kanazawa University, Ishikawa 920-8640, Japan
Mouse embryonic stem (ES) cells can self-renew in the presence of leukemia inhibitory factor (LIF). Several essential transcription factors have been identified for the self-renewal of mouse ES cells, including STAT3, Oct-3/4, and Nanog. The molecular mechanism of ES cell self-renewal, however, is not fully understood. In the present study, we identified Eed, a core component of Polycomb repressive complex 2, as a downstream molecule of STAT3 and Oct-3/4. Artificial activation of STAT3 resulted in increased expression of Eed, whereas expression of a dominant negative mutant of STAT3 or suppression of Oct-3/4 expression led to down-regulation of Eed. Reporter, chromatin immunoprecipitation, and electrophoretic mobility shift assays revealed that STAT3 and Oct-3/4 directly bind to the promoter region of Eed, suggesting that Eed is a common target molecule of STAT3 and Oct-3/4. We also found that suppression of STAT3, Oct-3/4, or Eed causes induction of differentiation-associated genes as well as loss of Lys27-trimethylated histone H3 at the promoter regions of the differentiation-associated genes. Suppression of STAT3 and Oct-3/4 also resulted in the absence of Eed at the promoter regions. These results suggest that STAT3 and Oct-3/4 maintain silencing of differentiation-associated genes through up-regulation of Eed in self-renewing ES cells.
Received for publication, August 30, 2007
, and in revised form, January 16, 2008.
* This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables S1 and S2.
1 Present address: Functional Genomics, Molecular Medicine Research Laboratories, Drug Discovery Research, Astellas Pharma Inc., Tsukuba, Ibaraki, Japan.
2 Present address: Division of Hematology and Oncology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048.
3 Present address: Dept. of Genetics and Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115.
4 To whom correspondence should be addressed: Dept. of Stem Cell Biology, Graduate School of Medical Science, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8640, Japan. Tel.: 81-76-265-2207; Fax: 81-76-234-4238; E-mail: hkoide{at}med.kanazawa-u.ac.jp.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B.V. Johnson, N. Shindo, P.D. Rathjen, J. Rathjen, and R.A. Keough
Understanding pluripotency--how embryonic stem cells keep their options open
Mol. Hum. Reprod.,
September 1, 2008;
14(9):
513 - 520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Chamberlain, D. Yee, and T. Magnuson
Polycomb Repressive Complex 2 Is Dispensable for Maintenance of Embryonic Stem Cell Pluripotency
Stem Cells,
June 1, 2008;
26(6):
1496 - 1505.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|